| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013283507 |
| P356 | DOI | 10.1038/KI.1973.92 |
| P698 | PubMed publication ID | 4355426 |
| P2093 | author name string | Bricker NS | |
| Slatopolsky E | |||
| P2860 | cites work | On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog | Q34057611 |
| Tracer microinjection study of renal tubular phosphate reabsorption in the rat. | Q34074028 | ||
| The control of phosphate excretion in uremia | Q34081512 | ||
| Control of phosphate excretion in uremic man | Q34277981 | ||
| MICROPUNCTURE STUDY OF INORGANIC PHOSPHATE EXCRETION IN THE RAT. | Q35569231 | ||
| The role of phosphate in the secretion of parathyroid hormone in man | Q37710802 | ||
| On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis". | Q39914380 | ||
| Calcium, Phosphorus, and Bone in Renal Disease and Transplantation | Q39979389 | ||
| On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using “proportional reduction” of dietary phosphorus intake | Q53861205 | ||
| Vitamin D metabolism: the role of kidney tissue. | Q54633053 | ||
| Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism | Q59054519 | ||
| Evaluation by Radioimmunoassay of Factors Controlling the Secretion of Parathyroid Hormone: Intravenous Infusions of Calcium and Ethylenediamine Tetraacetic Acid in the Cow and Goat | Q59075707 | ||
| Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease | Q70488705 | ||
| Micropuncture study of handling of phosphate by proximal and distal nephron in normal and parathyroidectomized rat. Evidence for distal reabsorption | Q71557783 | ||
| Demonstration of distal tubular flux of phosphorus using modified stop-flow analysis | Q72839078 | ||
| Regulation of Parathyroid Hormone Secretion: Proportional Control by Calcium, Lack of Effect of Phosphate1 | Q93774280 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hyperparathyroidism | Q1344835 |
| secondary hyperparathyroidism | Q3622611 | ||
| P304 | page(s) | 141-145 | |
| P577 | publication date | 1973-08-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease | |
| P478 | volume | 4 |
| Q36308619 | "Phosphatonins" and the regulation of phosphorus homeostasis |
| Q37276108 | A rat model of chronic kidney disease-mineral bone disorder |
| Q41204671 | Benefits of calcitriol therapy and serum phosphorus control in dogs and cats with chronic renal failure. Both are essential to prevent of suppress toxic hyperparathyroidism |
| Q70378361 | Biochemical parameters in chronic renal failure |
| Q41938087 | Bowel obstruction occurring in a child during treatment with aluminum hydroxide gel |
| Q67804871 | Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol |
| Q37182739 | Calcimimetics in chronic kidney disease: evidence, opportunities and challenges |
| Q38097111 | Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease. |
| Q48038085 | Calcium Homeostasis in Health and in Kidney Disease |
| Q42224046 | Calcium carbonate is an effective phosphorus binder in children with chronic renal failure |
| Q33972566 | Calcium metabolism in renal failure |
| Q41101802 | Calcium, phosphate, vitamin D, and the parathyroid |
| Q40633559 | Chronic renal insufficiency |
| Q72895780 | Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone |
| Q70994256 | Determinants of serum 1,25(OH)2D levels in renal disease |
| Q36849325 | Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics |
| Q51759821 | Development of a label-free assay for sodium-dependent phosphate transporter NaPi-IIb. |
| Q40313404 | Dialysate calcium and plasma calcium fractions during and after haemodialysis |
| Q24187142 | Dietary interventions for mineral and bone disorder in people with chronic kidney disease |
| Q24201392 | Dietary interventions for mineral and bone disorder in people with chronic kidney disease |
| Q40587215 | Dietary management of renal senescence and failure in dogs |
| Q42558853 | Differential effects of 1,25-(OH)2D3 and 22-oxacalcitriol on phosphate and calcium metabolism |
| Q55153837 | Diseases of the urinary system. renal osteodystrophy. |
| Q36577170 | Drug Insight: renal indications of calcimimetics |
| Q73544648 | Early posttransplant calcemia as a predictive indicator for parathyroidectomy in kidney allograft recipients with tertiary hyperparathyroidism |
| Q35208799 | Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency |
| Q41508632 | Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the "trade-off hypothesis". |
| Q50986471 | Enrollment parathyroid hormone level is a new marker of survival in hemodialysis and peritoneal dialysis therapy for uremia. |
| Q38123396 | FGF-23 and secondary hyperparathyroidism in chronic kidney disease |
| Q33944788 | Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism |
| Q55016620 | Getting Out of the Phosphate Bind: Trials to Guide Treatment Targets. |
| Q67776397 | Hyperparathyroidism after kidney transplantation: a retrospective case controlled study |
| Q67263673 | Hyperparathyroidism in renal failure |
| Q35994100 | Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease |
| Q70390677 | Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism |
| Q35922978 | Lower serum bicarbonate and a higher anion gap are associated with lower cardiorespiratory fitness in young adults |
| Q46471367 | Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure |
| Q45197415 | Optimal correction of acidosis changes progression of dialysis osteodystrophy |
| Q42511435 | Parathyroid gland function in chronic renal failure |
| Q38028534 | Parathyroid gland regulation: contribution of the in vivo and in vitro models. |
| Q39246280 | Parathyroid hormone and 1,25(OH)2D3 in chronic renal failure |
| Q35750628 | Parathyroid hormone gene expression in hypophosphatemic rats |
| Q38572880 | Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease. |
| Q37364439 | Phosphate and the parathyroid |
| Q69496140 | Phosphate depletion arrests progression of chronic renal failure independent of protein intake |
| Q37355688 | Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro |
| Q57224706 | Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure |
| Q69771326 | Prevention and reversal of progressive secondary hyperparathyroidism in patients maintained by hemodialysis |
| Q43018708 | Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. |
| Q38620775 | Recent developments in aluminum toxicology |
| Q39280064 | Renal Osteodystrophy-Time for Common Nomenclature |
| Q40616661 | Renal bone disease. |
| Q34436411 | Renal osteodystrophy |
| Q71272803 | Renal osteodystrophy |
| Q39641200 | Renal osteodystrophy: some new questions on an old disorder |
| Q38086888 | Renal pathophysiology: lessons learned from the canine remnant kidney model |
| Q37095085 | Renal phosphate handling: Physiology |
| Q45681091 | Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial |
| Q44544709 | Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race |
| Q68702617 | Secondary hyperparathyroidism in rats with experimentally induced pyelonephritis |
| Q70828822 | Serum 25-hydroxycalciferol concentrations in normal subjects and in haemodialysed patients with chronic renal failure |
| Q69139475 | Symptomatic skeletal disease in non-terminal renal failure |
| Q50101289 | The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease |
| Q34326197 | The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia |
| Q42018858 | The effect of uninephrectomy on mineral metabolism in normal human kidney donors |
| Q37789651 | The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals. |
| Q83202578 | The phosphatonins and the regulation of phosphate homeostasis |
| Q37821623 | The regulation of parathyroid hormone secretion and synthesis |
| Q38086910 | The role of phosphorus in the pathophysiology of chronic kidney disease. |
| Q42552111 | Use of phosphonoformic acid to induce phosphaturia in chronic renal failure in rats |
| Q67759000 | [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)] |
| Q39812781 | αKlotho and Chronic Kidney Disease |
Search more.